Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.
about
Astrogliosis in CNS pathologies: is there a role for microglia?Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.Is periventricular leukomalacia an axonopathy as well as an oligopathy?Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisIntense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritisAxonal damage in multiple sclerosis.Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.Toward biomarkers in multiple sclerosis: new advances.CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesCerebrospinal fluid in multiple sclerosis.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.Review on intermediate filaments of the nervous system and their pathological alterations.Molecular biomarkers of neurodegeneration.Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.The cerebrospinal fluid in multiple sclerosis: far beyond the bands.Secondary Progressive Multiple Sclerosis: Definition and Measurement.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration.Evidence for acute neurotoxicity after chemotherapy.Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis.Acute axonal damage predicts clinical outcome in patients with multiple sclerosis.Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis.Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.Neurofilament light chain predicts disease activity in relapsing-remitting MS.Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.MRI and multiple sclerosis-the evolving role of MRI in the diagnosis and management of MS: a clinician's perspective.Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
P2860
Q23911551-47F5C4A4-A1C9-4DAE-80D9-0C16692A7E88Q33610029-18EAA374-742E-4314-B698-A2291E2499B8Q34192650-2D7F717F-5D59-4091-AA72-4A7DD4AA73E9Q34422726-B4FB52AB-56A3-47EA-B045-0CC41E4309C2Q34524908-0BE5146D-E16D-48D2-BCDD-57F39D26B726Q34718044-5FCE8779-DA70-4A11-8DA2-69E6121E2864Q35015106-7C29002A-6E03-463D-94D2-ACB039713F55Q35126104-38A1A2D0-99C7-4B30-A55B-4AB09B65885FQ35364112-A552F32A-FE2F-42CD-B0A1-CFF40E9F4D7BQ35485799-173FB89B-966A-4516-A90B-066CA48EB980Q36492380-FBC554CD-954B-48A9-8156-28453522003EQ36840016-1EE85A72-767B-40D3-8D9F-8AD6C74E2116Q37206262-E995923A-F45F-40F4-B010-78DCD21E0746Q37690301-AC3D59D6-F8E3-4E8D-997E-3F3B03638125Q37698240-A01E2D51-EFD9-46B5-B042-785A66AC38E5Q38088747-57DE1BCC-3279-4A4A-8309-BD82A1D46C7DQ38113164-B03C1566-8DB5-4C8F-BEDE-E69DE891C42DQ38154930-3CB617B3-6A60-43BE-AD7C-0BC3FD905B92Q38682945-3C350082-EBDC-4B5E-94A6-564FB8DA65A4Q38737766-2207AD87-AB03-4AFC-90DD-FE9931B02ABAQ38782456-CCAF8CE7-5616-47D3-951E-31604A1C71F5Q38819421-8CACD767-3921-4907-8CF2-CE9923EBF526Q38831720-6E031417-86DB-47C2-BF09-819AD264B428Q38984981-F2920D14-5ECE-4074-B80A-0069BE8D605BQ39339614-8ADC8636-19F0-4050-9C77-B8EE90385452Q42769499-BE7D1BDB-80DD-4B0B-85DF-036A7258AC30Q43867547-4F6D4804-CFED-4C2D-9057-92E977BE9348Q44028578-CD17128D-E950-47C4-85A6-E3CCCF420488Q44813071-8E89C268-87BA-4F13-9C1F-CCA3839D8FABQ46727880-CFCD8471-2596-48F8-A5BB-D77BE009DA33Q46899417-93A5DFBB-23BA-4097-ADC1-71CAF7E3EFD7Q46910370-D9F73725-D985-4250-8BF9-EB292FFF5332Q47138197-74AAC3CE-4C7D-4A48-B971-B490F6474E10Q47144073-613E01C5-F17B-4686-BB73-2A17BCAB8CC8Q47579410-F65A8F47-CFE5-4589-B6D8-3472073809CEQ47638443-1F0DD99A-6C2F-4A39-86C4-8A875FD14838Q48172708-78F91769-566B-4075-A88C-554CA1760F1EQ49015259-2424B9FB-8474-4849-8CAE-905861D7F9B0Q50092008-72CF94EF-7B9D-41FE-851F-6D4A35E302A9Q50777713-A12C904B-4EEB-44BB-BC83-F24BAEFCBAAA
P2860
Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Neurofilament protein in cereb ...... ctivity in multiple sclerosis.
@en
type
label
Neurofilament protein in cereb ...... ctivity in multiple sclerosis.
@en
prefLabel
Neurofilament protein in cereb ...... ctivity in multiple sclerosis.
@en
P356
P1476
Neurofilament protein in cereb ...... activity in multiple sclerosis
@en
P2093
J E Karlsson
O Andersen
P304
P356
10.1136/JNNP.64.3.402
P407
P577
1998-03-01T00:00:00Z